お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は老年医学市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは老年医学の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の老年医学市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは老年医学のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に老年医学市場を分類しています。本研究に含まれる主な企業は：GSK、Boehringer Ingelheim、Novartis、Bristol-Myers Squibb、Pfizer、Eli Lilly、Abbott、AstraZeneca、Merck、Sanofi S.A.

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Analgesics
    Antihypertensives
    Statins
    Antidiabetics
    Proton Pump Inhibitor
    Anticoagulant
    Antipsychotic
    Antidepressant

用途別の市場セグメント：
    Cardiovascular
    Arthritis
    Neurological
    Cancer
    Osteoporosis
    Respiratory

本レポートの詳細内容
世界の老年医学市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、老年医学タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の老年医学収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の老年医学市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、老年医学市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

老年医学のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：老年医学のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：老年医学の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章老年医学企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：老年医学の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：老年医学の主要企業の概要を提供し、製品の説明と仕様、老年医学の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Market Analysis and Insights: Global Geriatric Medicine Market
The global Geriatric Medicine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Geriatric Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Geriatric Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Geriatric Medicine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Geriatric Medicine include GSK, Boehringer Ingelheim, Novartis, Bristol-Myers Squibb, Pfizer, Eli Lilly, Abbott, AstraZeneca and Merck, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Geriatric Medicine is widely used in various fields, such as Cardiovascular, Arthritis, Neurological and Cancer, etc. Cardiovascular provides greatest supports to the Geriatric Medicine industry development. In 2023, global % revenue of Geriatric Medicine went into Cardiovascular filed and the proportion will reach to % in 2030. 
Report Covers:
This report presents an overview of global market for Geriatric Medicine market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Geriatric Medicine, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Geriatric Medicine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Geriatric Medicine revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Geriatric Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Geriatric Medicine revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including GSK, Boehringer Ingelheim, Novartis, Bristol-Myers Squibb, Pfizer, Eli Lilly, Abbott, AstraZeneca and Merck, etc.

Market Segmentation
By Company
    GSK
    Boehringer Ingelheim
    Novartis
    Bristol-Myers Squibb
    Pfizer
    Eli Lilly
    Abbott
    AstraZeneca
    Merck
    Sanofi S.A.

Segment by Type
    Analgesics
    Antihypertensives
    Statins
    Antidiabetics
    Proton Pump Inhibitor
    Anticoagulant
    Antipsychotic
    Antidepressant

Segment by Application
    Cardiovascular
    Arthritis
    Neurological
    Cancer
    Osteoporosis
    Respiratory

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Geriatric Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Geriatric Medicine companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Geriatric Medicine revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Geriatric Medicine Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Analgesics
    Table 3. Key Players of Antihypertensives
    Table 4. Key Players of Statins
    Table 5. Key Players of Antidiabetics
    Table 6. Key Players of Proton Pump Inhibitor
    Table 7. Key Players of Anticoagulant
    Table 8. Key Players of Antipsychotic
    Table 9. Key Players of Antidepressant
    Table 10. Global Geriatric Medicine Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 11. Global Geriatric Medicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 12. Global Geriatric Medicine Market Size by Region (2019-2024) & (US$ Million)
    Table 13. Global Geriatric Medicine Market Share by Region (2019-2024)
    Table 14. Global Geriatric Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 15. Global Geriatric Medicine Market Share by Region (2025-2030)
    Table 16. Geriatric Medicine Market Trends
    Table 17. Geriatric Medicine Market Drivers
    Table 18. Geriatric Medicine Market Challenges
    Table 19. Geriatric Medicine Market Restraints
    Table 20. Global Geriatric Medicine Revenue by Players (2019-2024) & (US$ Million)
    Table 21. Global Geriatric Medicine Revenue Share by Players (2019-2024)
    Table 22. Global Top Geriatric Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geriatric Medicine as of 2023)
    Table 23. Global Geriatric Medicine Industry Ranking 2022 VS 2023 VS 2024
    Table 24. Global 5 Largest Players Market Share by Geriatric Medicine Revenue (CR5 and HHI) & (2019-2024)
    Table 25. Global Key Players of Geriatric Medicine, Headquarters and Area Served
    Table 26. Global Key Players of Geriatric Medicine, Product and Application
    Table 27. Global Key Players of Geriatric Medicine, Product and Application
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Geriatric Medicine Market Size by Type (2019-2024) & (US$ Million)
    Table 30. Global Geriatric Medicine Revenue Market Share by Type (2019-2024)
    Table 31. Global Geriatric Medicine Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 32. Global Geriatric Medicine Revenue Market Share by Type (2025-2030)
    Table 33. Global Geriatric Medicine Market Size by Application (2019-2024) & (US$ Million)
    Table 34. Global Geriatric Medicine Revenue Share by Application (2019-2024)
    Table 35. Global Geriatric Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 36. Global Geriatric Medicine Revenue Share by Application (2025-2030)
    Table 37. North America Geriatric Medicine Market Size by Type (2019-2024) & (US$ Million)
    Table 38. North America Geriatric Medicine Market Size by Type (2025-2030) & (US$ Million)
    Table 39. North America Geriatric Medicine Market Size by Application (2019-2024) & (US$ Million)
    Table 40. North America Geriatric Medicine Market Size by Application (2025-2030) & (US$ Million)
    Table 41. North America Geriatric Medicine Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 42. North America Geriatric Medicine Market Size by Country (2019-2024) & (US$ Million)
    Table 43. North America Geriatric Medicine Market Size by Country (2025-2030) & (US$ Million)
    Table 44. Europe Geriatric Medicine Market Size by Type (2019-2024) & (US$ Million)
    Table 45. Europe Geriatric Medicine Market Size by Type (2025-2030) & (US$ Million)
    Table 46. Europe Geriatric Medicine Market Size by Application (2019-2024) & (US$ Million)
    Table 47. Europe Geriatric Medicine Market Size by Application (2025-2030) & (US$ Million)
    Table 48. Europe Geriatric Medicine Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 49. Europe Geriatric Medicine Market Size by Country (2019-2024) & (US$ Million)
    Table 50. Europe Geriatric Medicine Market Size by Country (2025-2030) & (US$ Million)
    Table 51. China Geriatric Medicine Market Size by Type (2019-2024) & (US$ Million)
    Table 52. China Geriatric Medicine Market Size by Type (2025-2030) & (US$ Million)
    Table 53. China Geriatric Medicine Market Size by Application (2019-2024) & (US$ Million)
    Table 54. China Geriatric Medicine Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Geriatric Medicine Market Size by Type (2019-2024) & (US$ Million)
    Table 56. Asia Geriatric Medicine Market Size by Type (2025-2030) & (US$ Million)
    Table 57. Asia Geriatric Medicine Market Size by Application (2019-2024) & (US$ Million)
    Table 58. Asia Geriatric Medicine Market Size by Application (2025-2030) & (US$ Million)
    Table 59. Asia Geriatric Medicine Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 60. Asia Geriatric Medicine Market Size by Region (2019-2024) & (US$ Million)
    Table 61. Asia Geriatric Medicine Market Size by Region (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Geriatric Medicine Market Size by Type (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Geriatric Medicine Market Size by Type (2025-2030) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Geriatric Medicine Market Size by Application (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Geriatric Medicine Market Size by Application (2025-2030) & (US$ Million)
    Table 66. Middle East, Africa, and Latin America Geriatric Medicine Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 67. Middle East, Africa, and Latin America Geriatric Medicine Market Size by Country (2019-2024) & (US$ Million)
    Table 68. Middle East, Africa, and Latin America Geriatric Medicine Market Size by Country (2025-2030) & (US$ Million)
    Table 69. GSK Company Details
    Table 70. GSK Business Overview
    Table 71. GSK Geriatric Medicine Product
    Table 72. GSK Revenue in Geriatric Medicine Business (2019-2024) & (US$ Million)
    Table 73. GSK Recent Developments
    Table 74. Boehringer Ingelheim Company Details
    Table 75. Boehringer Ingelheim Business Overview
    Table 76. Boehringer Ingelheim Geriatric Medicine Product
    Table 77. Boehringer Ingelheim Revenue in Geriatric Medicine Business (2019-2024) & (US$ Million)
    Table 78. Boehringer Ingelheim Recent Developments
    Table 79. Novartis Company Details
    Table 80. Novartis Business Overview
    Table 81. Novartis Geriatric Medicine Product
    Table 82. Novartis Revenue in Geriatric Medicine Business (2019-2024) & (US$ Million)
    Table 83. Novartis Recent Developments
    Table 84. Bristol-Myers Squibb Company Details
    Table 85. Bristol-Myers Squibb Business Overview
    Table 86. Bristol-Myers Squibb Geriatric Medicine Product
    Table 87. Bristol-Myers Squibb Revenue in Geriatric Medicine Business (2019-2024) & (US$ Million)
    Table 88. Bristol-Myers Squibb Recent Developments
    Table 89. Pfizer Company Details
    Table 90. Pfizer Business Overview
    Table 91. Pfizer Geriatric Medicine Product
    Table 92. Pfizer Revenue in Geriatric Medicine Business (2019-2024) & (US$ Million)
    Table 93. Pfizer Recent Developments
    Table 94. Eli Lilly Company Details
    Table 95. Eli Lilly Business Overview
    Table 96. Eli Lilly Geriatric Medicine Product
    Table 97. Eli Lilly Revenue in Geriatric Medicine Business (2019-2024) & (US$ Million)
    Table 98. Eli Lilly Recent Developments
    Table 99. Abbott Company Details
    Table 100. Abbott Business Overview
    Table 101. Abbott Geriatric Medicine Product
    Table 102. Abbott Revenue in Geriatric Medicine Business (2019-2024) & (US$ Million)
    Table 103. Abbott Recent Developments
    Table 104. AstraZeneca Company Details
    Table 105. AstraZeneca Business Overview
    Table 106. AstraZeneca Geriatric Medicine Product
    Table 107. AstraZeneca Revenue in Geriatric Medicine Business (2019-2024) & (US$ Million)
    Table 108. AstraZeneca Recent Developments
    Table 109. Merck Company Details
    Table 110. Merck Business Overview
    Table 111. Merck Geriatric Medicine Product
    Table 112. Merck Revenue in Geriatric Medicine Business (2019-2024) & (US$ Million)
    Table 113. Merck Recent Developments
    Table 114. Sanofi S.A. Company Details
    Table 115. Sanofi S.A. Business Overview
    Table 116. Sanofi S.A. Geriatric Medicine Product
    Table 117. Sanofi S.A. Revenue in Geriatric Medicine Business (2019-2024) & (US$ Million)
    Table 118. Sanofi S.A. Recent Developments
    Table 119. Research Programs/Design for This Report
    Table 120. Key Data Information from Secondary Sources
    Table 121. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Geriatric Medicine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Geriatric Medicine Market Share by Type: 2023 VS 2030
    Figure 3. Analgesics Features
    Figure 4. Antihypertensives Features
    Figure 5. Statins Features
    Figure 6. Antidiabetics Features
    Figure 7. Proton Pump Inhibitor Features
    Figure 8. Anticoagulant Features
    Figure 9. Antipsychotic Features
    Figure 10. Antidepressant Features
    Figure 11. Global Geriatric Medicine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 12. Global Geriatric Medicine Market Share by Application: 2023 VS 2030
    Figure 13. Cardiovascular Case Studies
    Figure 14. Arthritis Case Studies
    Figure 15. Neurological Case Studies
    Figure 16. Cancer Case Studies
    Figure 17. Osteoporosis Case Studies
    Figure 18. Respiratory Case Studies
    Figure 19. Geriatric Medicine Report Years Considered
    Figure 20. Global Geriatric Medicine Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 21. Global Geriatric Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 22. Global Geriatric Medicine Market Share by Region: 2023 VS 2030
    Figure 23. Global Geriatric Medicine Market Share by Players in 2023
    Figure 24. Global Top Geriatric Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Geriatric Medicine as of 2023)
    Figure 25. The Top 10 and 5 Players Market Share by Geriatric Medicine Revenue in 2023
    Figure 26. North America Geriatric Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. North America Geriatric Medicine Market Share by Type (2019-2030)
    Figure 28. North America Geriatric Medicine Market Share by Application (2019-2030)
    Figure 29. North America Geriatric Medicine Market Share by Country (2019-2030)
    Figure 30. United States Geriatric Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Canada Geriatric Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Europe Geriatric Medicine Market Size YoY (2019-2030) & (US$ Million)
    Figure 33. Europe Geriatric Medicine Market Share by Type (2019-2030)
    Figure 34. Europe Geriatric Medicine Market Share by Application (2019-2030)
    Figure 35. Europe Geriatric Medicine Market Share by Country (2019-2030)
    Figure 36. Germany Geriatric Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. France Geriatric Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. U.K. Geriatric Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Italy Geriatric Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Russia Geriatric Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Nordic Countries Geriatric Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. China Geriatric Medicine Market Size YoY (2019-2030) & (US$ Million)
    Figure 43. China Geriatric Medicine Market Share by Type (2019-2030)
    Figure 44. China Geriatric Medicine Market Share by Application (2019-2030)
    Figure 45. Asia Geriatric Medicine Market Size YoY (2019-2030) & (US$ Million)
    Figure 46. Asia Geriatric Medicine Market Share by Type (2019-2030)
    Figure 47. Asia Geriatric Medicine Market Share by Application (2019-2030)
    Figure 48. Asia Geriatric Medicine Market Share by Region (2019-2030)
    Figure 49. Japan Geriatric Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. South Korea Geriatric Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. China Taiwan Geriatric Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Southeast Asia Geriatric Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. India Geriatric Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Australia Geriatric Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Middle East, Africa, and Latin America Geriatric Medicine Market Size YoY (2019-2030) & (US$ Million)
    Figure 56. Middle East, Africa, and Latin America Geriatric Medicine Market Share by Type (2019-2030)
    Figure 57. Middle East, Africa, and Latin America Geriatric Medicine Market Share by Application (2019-2030)
    Figure 58. Middle East, Africa, and Latin America Geriatric Medicine Market Share by Country (2019-2030)
    Figure 59. Brazil Geriatric Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. Mexico Geriatric Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 61. Turkey Geriatric Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 62. Saudi Arabia Geriatric Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 63. Israel Geriatric Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 64. GCC Countries Geriatric Medicine Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 65. GSK Revenue Growth Rate in Geriatric Medicine Business (2019-2024)
    Figure 66. Boehringer Ingelheim Revenue Growth Rate in Geriatric Medicine Business (2019-2024)
    Figure 67. Novartis Revenue Growth Rate in Geriatric Medicine Business (2019-2024)
    Figure 68. Bristol-Myers Squibb Revenue Growth Rate in Geriatric Medicine Business (2019-2024)
    Figure 69. Pfizer Revenue Growth Rate in Geriatric Medicine Business (2019-2024)
    Figure 70. Eli Lilly Revenue Growth Rate in Geriatric Medicine Business (2019-2024)
    Figure 71. Abbott Revenue Growth Rate in Geriatric Medicine Business (2019-2024)
    Figure 72. AstraZeneca Revenue Growth Rate in Geriatric Medicine Business (2019-2024)
    Figure 73. Merck Revenue Growth Rate in Geriatric Medicine Business (2019-2024)
    Figure 74. Sanofi S.A. Revenue Growth Rate in Geriatric Medicine Business (2019-2024)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed